International perspectives on newborn screening

  title={International perspectives on newborn screening},
  author={Rodney J. Pollitt},
  journal={Journal of Inherited Metabolic Disease},
The development of electrospray tandem mass spectrometry (MS-MS) has greatly increased the number of diseases that can be detected by newborn blood-spot screening. Different countries are introducing the technology at different rates and for different disease panels. Current policies in the United Kingdom, Germany and the United States are taken as examples. In the United Kingdom, many laboratories are using MS-MS for routine screening for phenylketonuria but, except for those participating in… CONTINUE READING